Veru Reaches Full Enrollment for Phase 2b QUALITY Clinical Study of Enobosarm for Obesity and Reports Fiscal 2024 Third Quarter Financial Results

Stock Information for Veru Inc.

Loading

Please wait while we load your information from QuoteMedia.